Sherryn Roth

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 276 citations · Full text

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program

Christopher M. O’Connor, Alan B. Miller, John E. Blair et al. · American Heart Journal · 2010 · 233 citations

Heart Failure, Cardiogenic Shock, Cardiovascular Disease +7

Thrombin Generation, Inhibition and Clinical Outcomes in Patients With Acute Myocardial Infarction Treated With Thrombolytic Therapy and Heparin: Results From the GUSTO-I Trial fn1fn1This study was supported by Genentech, Inc., South San Francisco, California; Bayer Corporation, New York, New York; CIBA-Corning, Medfield, Massachusetts; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.

Christopher B. Granger, Richard C. Becker, Russell P. Tracy et al. · Journal of the American College of Cardiology · 1998 · 80 citations

Thrombin Generation, Thrombosis, Cardiovascular Disease +13

Serial myoglobin quantitation in the early assessment of myocardial damage: A clinical study

D. A. Gornall, Sherryn Roth · Clinical Biochemistry · 1996 · 20 citations

Cardiomyopathy, Heart Failure, Cardiovascular Disease +12

Focal Epithelial Hyperplasia Caused by Human Papillomavirus 13

Natasha Saunders, Dennis Scolnik, Anuradha Rebbapragada et al. · The Pediatric Infectious Disease Journal · 2010 · 13 citations

Dna Sequencing, Cervical Cancer, Oral Cavity +10